Malaria - the formidable enemy of humanity

• Autorzy: Pawar A. , Pal A.
• Języki publikacji: EN

Abstrakty

EN

Malaria, a disease caused by protozoan parasite of the genus Plasmodium, is an ancient enemy of the human race. Despite enormous efforts to control, it is still a main cause of morbidity and mortality in many endemic countries of the world, particularly Africa, South of Sahara. Malaria seems to be unstoppable due to lack of an effective vaccine, acquisition of drug-resistance by malaria parasite, and insecticide resistance by Anopheles mosquitoes. In this scenario, along with search for novel preventive approaches, adequate health facilities, health literacy and awareness among people are required to control and eliminate this formidable disease from society.

Słowa kluczowe

EN

human disease; parasitic disease; Malaria; Plasmodium; clinical symptom; vector-borne disease; disease transmission; mosquito; Anopheles

• Wydawca: -
• Czasopismo: International Letters of Natural Sciences
• Rocznik: 2015
• Tom: 43
• Opis fizyczny: p.1-5,ref.

Twórcy

autor

Pawar A.

• Department of Zoology, DAV University, Jalandhar-144012, India

autor

Pal A.

• Department of Biochemistry, PGIMER, Chandigarh-160012, India

Bibliografia

• [1] P.L. Alonso, Malaria: deploying a candidate vaccine (RTS,S/AS02A) for an old scourge of humankind, Int. Microbiol. 9 (2006) 83-93.
• [2] A. Laveran, “Traite des fievres palusters”, Doin, Paris, 1884.
• [3] P. Manson, On the nature and significance of the crecentic and flagellated bodies in malarial blood, Br. Med. J2 (1894) 1306-1308.
• [4] R. Ross, “Report on the cultivation of Proteosoma labbe in Grey Mosquitoes”. Government press, Calcutta, 1898.
• [5] B. Grassi, A. Bignami, G. Bastianelli, Cido evolution delle semilune nell Anopheles claviger, Atti. Soc. Studi. Malar. 1 (1899) 14.
• [6] G. Bastianelli, A. Bignami, Sullo suilappo dei parassiti della terzana nell Anopheles claviger, Atti. Soc. Studi. Malar. 1 (1899) 28-49.
• [7] G. Raffaele, Un Ceppo italiano di Plasmodium elongatum, Riv. Malariol. 13 (1934) 3-8.
• [8] H.E. Shortt, P.C.C. Garnham, The pre-erythrocytic development of P. cyanomolgi and P. vivax, Trans. R. Soc. Trop. Med. Hyg. 41 (1948) 785-795.
• [9] H.E. Shortt, N.H. Feirley, G. Covell, P.G. Shute, P.C.C. Garnham, The pre-erythrocytic stages of Plasmodium falciparum, Trans. R. Soc. Trop. Med. Hyg. 44 (1951) 405-419.
• [10] C.J. Murray, L.C. Rosenfeld, S.S. Lim, K.G. Andrews, K.J. Foreman, D. Haring, N. Fullman, M. Naghavi, R. Lozano, A.D. Lopez, Global malaria mortality between 1980 and 2010: a systematic analysis, Lancet. 379 (2012) 413-431.
• [11] WHO, World malaria report, 2012, WHO press, Geneva, ISBN 978 92 4 156453 3, 2012.
• [12] C.B. Holmes, E. Losina, R.P. Walensky, Y. Yazdanpanah, K.A. Freedberg, Review of human immunodeficiency virus type 1-related opportunistic infections in sub-Saharan Africa, Clin. Infect. Dis. 36 (2003) 652−662.
• [13] C. Flateau, G. Le Loup, G. Pialoux, Consequences of HIV infection on malaria and therapeutic implications: a systematic review, Lancet Infect. Dis. 11 (2011) 541–556.
• [14] WHO, World malaria report, 2011, WHO press, Geneva, ISBN 978 92 4 156440 3, 2011.
• [15] M.T. Al-Maktari, H.K. Bassiouny, Z.S. Al-Hamd, A.M. Assabri, A.G. El-Massry, H.Z. Shatat, Malaria status in Al-Hodeidah Governorate, Yemen: malariometric parasitic survey and chloroquine resistance P. falciparum local strain, J. Egypt. Soc. Parasitol. 33 (2003) 361–372.
• [16] K.M. Lekweiry, M.O. Abdallahi, H. Ba, C. Arnathau, P. Durand, J.F. Trape, A.O. Salem, Preliminary study of malaria incidence in Nouakchott, Mauritania, Malar. J. 8 (2009) 92–98.
• [17] J. Cox-Singh, T.M. Davis, K.S. Lee, S.S. Shamsul, A. Matusop, S. Ratnam, H.A. Rahman, D.J. Conway, B. Singh, Plasmodium knowlesi malaria in humans is widely distributed and potentially life threatening, Clin. Infect. Dis. 46 (2008) 165-171.
• [18] J. Cox-Singh, B. Singh, Knowlesi malaria: newly emergent and of public health importance?, Trends. Parasitol. 24 (2008) 406–410.
• [19] R.N. Price, N.M. Douglas, N.M. Anstey, New developments in Plasmodium vivax malaria: severe disease and the rise of chloroquine resistance, Curr. Opin. Infect. Dis. 22 (2009) 430-435.
• [20] J.-M. Kang, M. Sung-Ung, K. Jung-Yeon, C. Shin-Hyeong, K. Lin, S. Woon-Mok, K. Tong-Soo, N. Byoung-Kuk, Genetic polymorphism of merozoite surface protein-1 and merozoite surface protein-2 in Plasmodium falciparum field isolates from Myanmar, Malar. J. 9 (2010) 131.
• [21] M.M. Stevenson, R. Ing, F. Berretta, J. Miu, Regulating the adaptive immune response to blood-stage malaria: role of dendritic cells and CD4+Foxp3+ regulatory T cells, Int. J. Biol. Sci. 7 (2011) 1311-1322.
• [22] E. Tjitra, N.M. Anstey, P. Sugiarto, N. Warikar, E. Kenangalem, M. Karyana, D.A. Lampah, R.N. Price, Multidrug-resistant Plasmodium vivax associated with severe and fatal malaria: a prospective study in Papua, Indonesia, PLoS. Med. 5e (2008) 128.
• [23] K.E. Kester, J.F. Cummings, O. Ofori-Anyinam, C.F. Ockenhouse, U. Krzych, P. Moris, R. Schwenk, R.A. Nielsen, Z. Debebe, E. Pinelis, L. Juompan, J. Williams, M. Dowler, V.A. Stewart, R.A. Wirtz, M.C. Dubois, M. Lievens, J. Cohen, W.R. Ballou, D.G. Heppner, Randomized, doubleblind, phase 2a trial of falciparum malaria vaccines RTS,S/AS01B and RTS,S/AS02A in malarianaive adults: safety, efficacy, and immunologic associates of protection, J. Infect. Dis. 200 (2009) 337–346.
• [24] S.K. Prajapati, H. Joshi, V.K. Dua, Antigenic repertoire of Plasmodium vivax transmissionblocking vaccine candidates from the Indian subcontinent, Malar. J. 10 (2011) 111.
• [25] H.K. Heggenhouegen, V. Hackethal, P. Vivek, The behavioural and social aspects of malaria and its control, UNDP/World Bank/WHO Special Programme for Research and Training in Tropical Diseases (TDR), 2003.
• [26] K. Raghavendra, T.K. Barik, B.P.N. Reddy, P. Sharma, A.P. Dash, Malaria vector control: from past to future, Parasitol. Res. 108 (2011) 757–779.
• [27] J. Sachs, P. Malaney, The economic and social burden of malaria, Nature. 415 (2002) 680-685.
• [28] M.F. Good, Vaccine-induced immunity to malaria parasites and the need for novel strategies, Trends. Parasitol. 21(2005) 29-34.
• [29] C.E. Matisz, P. Naidu, S.E. Shokoples, D. Grice, V. Krinke, S.Z. Brown, K. Kowalewska- Grochowska, S. Houston, S.K. Yanow, Post-arrival screening for malaria in asymptomatic refugees using real time PCR, Am. J. Trop. Med. Hyg. 84 (2011) 161-165.
• [30] K. Artavanis-Tsakonas, J.E. Tongren, E.M. Riley, The war between the malaria parasite and the immune system: immunity, immunoregulation and immunopathology, Clin. Exp. Immunol. 133 (2003) 145-152.
• [31] M.B.B. McCall, R.W. Sauerwein, Interferon gamma-central mediator of protective immune responses against the pre-erythrocytic and blood stage of malaria, J. Leukoc. Biol. 88 (2010) 1131-1143.
• [32] A. Teklehaimanot, G.C. McCord, J.D. Sachs, Scaling up malaria control in Africa: an economic and epidemiological assessment, Am. J. Trop. Med. Hyg. 77 (2007) 138-144.
• [33] P. Mocumbi, Plague of my people, Nature. 430 (2004) 925.

Identyfikatory

DOI

10.18052/www.scipress.com/ILNS.43.1